Comorbidity in multiple sclerosis: its temporal relationships with disease onset and dose effect on mortality.

Chou, I J; Kuo, C F; Tanasescu, R; Tench, C R; Tiley, C G; Constantinescu, C S; Whitehouse, W P

Chou, I J; Kuo, C F; Tanasescu, R; Tench, C R; Tiley, C G; Constantinescu, C S; Whitehouse, W P.

Afiliação

Chou IJ; Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Kuo CF; Division of Academic Child Health, School of Medicine, University of Nottingham, Nottingham, UK.
Tanasescu R; Division of Paediatric Neurology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Tench CR; Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Nottingham, UK.
Tiley CG; Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Constantinescu CS; Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
Whitehouse WP; Division of Neurosciences, Department of Neurology, Colentina Hospital, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.

Eur J Neurol ; 27(1): 105-112, 2020 01.

Article em En | MEDLINE | ID: mdl-31309645

Assuntos

Esclerose Múltipla/complicações; Esclerose Múltipla/mortalidade; Adulto; Idade de Início; Causas de Morte; Comorbidade; Feminino; Humanos; Incidência; Masculino; Pessoa de Meia-Idade; Medição de Risco; Análise de Sobrevida; Reino Unido/epidemiologia

Palavras-chave

multiple sclerosis; comorbidity; mortality

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google